Figure 1.

Study overview. A total of 50 pregnant women with obesity received either Vivomixx® probiotic or a placebo treatment from 14–20 weeks of gestation until birth. Administration of probiotics significantly increased the diversity of the GM compared to the placebo group as published elsewhere.³⁴ for the remainder of the study period, 47 infants were included with physical examination and health questionaries, besides having fecal samples collected 3 d, 3 months, 6 months, and 9 months after birth. This was done to evaluate whether the maternal prenatally supplemented probiotics influenced infant GM diversity and relative abundance. This figure was created with BioRender.com.